Drug Trial Radar · NCT02195817
Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care
Last checked: Nov 20, 2026Latest source record: Feb 28, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
378
Actual
Start
Aug 2014
Primary completion
Feb 2016
Study completion Feb 2016
Sponsor
- Lead sponsor
- H. Lundbeck A/SIndustry
- Sponsor type
- Industry
- First posted
- Jul 21, 2014
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To determine the reduction in alcohol consumption in patients with alcohol dependence treated with 18 mg Selincro® as-needed use, in conjunction with continuous psychosocial support in primary care
Conditions
- Alcohol Dependence
Interventions
Selincro® 18 mg with continuous psychosocial support: Cohort ADrug
Initial psychosocial support: Cohort BOther
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in the number of Heavy Drinking Days (HDDs) (days/month)Time frame: Baseline to Month 3
Locations
48 sites in 4 countries. Site status is shown where the registry gives one.
FR010
Bécon-les-Granits, France
FR001
Bordeaux, France
FR005
Bordeaux, France
FR009
Cestas, France
FR012
Chauny, France
FR002
Coulounieix-Chamiers, France
FR008
La Teste-de-Buch, France
FR007
Mont-de-Marsan, France
FR011
Narbonne, France
FR003
Targon, France
FR006
Tonneins, France
FR004
Vieux-Boucau-les-Bains, France
DE002
Berlin, Germany
DE005
Berlin, Germany
DE006
Essen, Germany
DE003
Jahnsdorf, Germany
DE004
Jahnsdorf, Germany
DE011
Mannheim, Germany
DE009
Nuremberg, Germany
DE010
Offenbach, Germany
DE001
Wallerfing, Germany
DE007
Weilburg, Germany
DE008
Weinheim, Germany
ES001
Badalona, Spain
ES010
Badalona, Spain
ES003
Barcelona, Spain
ES004
Barcelona, Spain
ES008
Canet de Mar, Spain
ES007
el Prat de Llobregat, Spain
ES006
Hospitalet Del Llobregat, Spain
ES009
Hospitalet Del Llobregat, Spain
ES011
Hospitalet Del Llobregat, Spain
ES013
Matar, Spain
ES002
Mataró, Spain
ES012
Sabadell, Spain
ES005
Tarragona, Spain
GB011
Ballymena, United Kingdom
GB008
Belfast, United Kingdom
GB009
Belfast, United Kingdom
GB004
Cardiff, United Kingdom
Showing 40 of 48 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.